Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danna M Breen

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Atherosclerosis|May 4, 2012
Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanismDanna M Breen, Vernon W Dolinsky, Hangjun Zhang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 11, 2009
Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injuryDanna M Breen, Kalam K Chan, Jiwanjeet K Dhaliwall, et al.
Metabolism: Clinical and Experimental|December 4, 2014
In vivo effects of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivitySandra Pereira, Danna M Breen, Anthony E Naassan, et al.
Journal of Vascular Research|August 11, 2020
Resveratrol Inhibits Neointimal Growth after Arterial Injury in High-Fat-Fed Rodents: The Roles of SIRT1 and AMPKJune Guo, Troy J Pereira, Yusaku Mori, et al.
Atherosclerosis|May 15, 2015
The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependentJune Guo, Danna M Breen, Troy J Pereira, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 13, 2026
Targeting Cancer Cachexia: A Mechanistic Evaluation of Anti-GDF-15 Antibody-Based Combination TherapiesDanna M Breen, Stephanie Joaquim, Brianna LaCarubba Paulhus, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 18, 2024
Frequency of weight and body composition increases in advanced non-small cell lung cancer patients during first line therapyPhilip Bonomi, Hita Moudgalya, Sandra L Gomez, et al.
Cell Metabolism|November 18, 2020
GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman PrimatesDanna M Breen, Hanna Kim, Donald Bennett, et al.
Iscience|June 30, 2021
Growth differentiation factor 15 neutralization does not impact anorexia or survival in lipopolysaccharide-induced inflammationDanna M Breen, Srinath Jagarlapudi, Anita Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2021
Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15Irene Cimino, Hanna Kim, Y C Loraine Tung, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Atherosclerosis|May 4, 2012
Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanismDanna M Breen, Vernon W Dolinsky, Hangjun Zhang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 11, 2009
Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injuryDanna M Breen, Kalam K Chan, Jiwanjeet K Dhaliwall, et al.
Metabolism: Clinical and Experimental|December 4, 2014
In vivo effects of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivitySandra Pereira, Danna M Breen, Anthony E Naassan, et al.
Journal of Vascular Research|August 11, 2020
Resveratrol Inhibits Neointimal Growth after Arterial Injury in High-Fat-Fed Rodents: The Roles of SIRT1 and AMPKJune Guo, Troy J Pereira, Yusaku Mori, et al.
Atherosclerosis|May 15, 2015
The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependentJune Guo, Danna M Breen, Troy J Pereira, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 13, 2026
Targeting Cancer Cachexia: A Mechanistic Evaluation of Anti-GDF-15 Antibody-Based Combination TherapiesDanna M Breen, Stephanie Joaquim, Brianna LaCarubba Paulhus, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 18, 2024
Frequency of weight and body composition increases in advanced non-small cell lung cancer patients during first line therapyPhilip Bonomi, Hita Moudgalya, Sandra L Gomez, et al.
Cell Metabolism|November 18, 2020
GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman PrimatesDanna M Breen, Hanna Kim, Donald Bennett, et al.
Iscience|June 30, 2021
Growth differentiation factor 15 neutralization does not impact anorexia or survival in lipopolysaccharide-induced inflammationDanna M Breen, Srinath Jagarlapudi, Anita Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2021
Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15Irene Cimino, Hanna Kim, Y C Loraine Tung, et al.
Pageof 4